Federal and Regulatory Outreach

AMRPA Comments on CY 2026 MA Proposed Rule

January 27, 2025
Medicare Advantage

AMRPA Comments on CMS ICR Internal Criteria and Audit Protocol

November 12, 2024
Medicare Advantage Prior Authorization Regulatory

AMRPA Comments on CMS Proposed Service Level Data Collection for MA Plans

October 8, 2024
Medicare Advantage Prior Authorization Regulatory

AMRPA Comments on Request for Information on Medicare Advantage Data

May 31, 2024
Medicare Advantage Prior Authorization Regulatory

AMRPA Comments on CY 2025 Medicare Advantage Proposed Rule

January 5, 2024
Medicare Advantage Prior Authorization Regulatory

AMRPA Sign-On Letter to Request Sub-Regulatory Guidance on CY2024 MA Rule

December 6, 2023
Medicare Advantage Prior Authorization Regulatory

AMRPA Comments on Senate HELP Committee on AI in Healthcare

September 22, 2023
Legislative Medicare Advantage Prior Authorization

AMRPA Submits Comments for Congressional Hearing on MA Denials and Delays

June 2, 2023
Legislative Medicare Advantage Prior Authorization

AMRPA Comment Letter re: CY 2024 Policy and Technical Changes to MA Program Proposed Rule

February 14, 2023
Medicare Advantage Prior Authorization Regulatory

AMRPA Response to CMS MA RFI on Health Equity & Access Issues in the Medicare Advantage Program

September 1, 2022
Medicare Advantage Prior Authorization Regulatory

Report: Medicare Advantage Prior Authorization

March 8, 2022
Medicare Advantage Prior Authorization

Response to CMS Request for Information on Prior Authorization

March 8, 2022
Medicare Advantage Prior Authorization Regulatory
Scroll to Top
Skip to content